iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Sun Pharma's US arm completes acquisition of subsidiary companies of Galderma; Stock climbs 1.5%

9 Mar 2022 , 09:20 AM

Sun Pharma

Sun Pharmaceutical Industries Limited Subsidiary Taro Pharmaceuticals USA Inc has completed the acquisition of subsidiary companies of Galderma, company said in a regulatory filing on Tuesday.

The acquired subsidiaries of Galderma included Galderma Holdings Inc which was incorporated in Delaware, Proactiv YK which was incorporated in Japan, and The Proactiv Company Corporation which was incorporated in Canada.

These subsidiaries sold products under the Proactiv, Restorative Elements and In Defense of Skin brands. The company paid $99.279 million for the entire transaction.

At around 9.24 am, Sun Pharmaceuticals Industries Ltd was trading at Rs869.20 per piece up by Rs13.65 or 1.6% from its previous closing of Rs855.55 per piece on the BSE.

Related Tags

  • acquisition
  • Galderma
  • subsidiary companies
  • Sun Pharma news
  • Sun Pharma share price
  • Sun Pharma stock price
  • Sun Pharmaceutical Industries Limited
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

AWL Agri Q4 Profit Rises 21%
29 Apr 2025|11:48 AM
Indices may open flat on April 29, 2025
29 Apr 2025|09:10 AM
TVS Motors net profit surges 76% y-o-y
29 Apr 2025|08:39 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.